title: High concentration plasma-reduced plateletapheresis concentrates.
abstract: Single-donor hyperconcentrated plateletapheresis (dry-platelets) collection has been introduced in the 90's as a part of the newly developed multi-component collection strategy. This approach allowed to safely collect multiple components from a single apheresis donation, i.e. RBC, FFP and/or plateletpheresis units. Dry-platelets are usually resuspended in additive solution to maintain an adequate pH during the storage period until use. Some concern existed about possible higher degrees of platelet activation in dry-platelets units when compared to standard concentration (1.0-1.6 × 10(6)/μL platelets) units and its possible correlation with lower in vivo efficiency and/or survival of the former units. Several authors investigated this specific issue, and dry-platelets units proved to be equally effective than standard concentration plateletpheresis units in recipients. The use of dry-platelets units may reduce (i) the risk of passive infusion of naturally occurring ABO-related hemolytic antibodies when donor O platelets are given to group A, B, or AB recipient, (ii) the risk of TRALI when multiparous donors undergo plateletpheresis. Furthermore, dry-platelet collection may allow for an increased amount of FFP sent to industry. Finally, hyperconcentrated platelet units may be used for "niche" indications, such as intrauterine platelet transfusion or, in case of autologous dry-platelet collection, for further freezing for long term storage in selected patients within onco-hematological settings.
authors.affiliation: UOS Aferesi e nuove tecnologie trasfusionali, Dipartimento di Patologia Clinica-Ospedale San Gerardo, Via Pergolesi 33, 20052 Monza (MB), Italy. p.perseghin@hsgerardo.org
authors.forename: Paolo
authors.initials: P
authors.lastname: Perseghin
mesh_terms: D000017:ABO Blood-Group System / Q000097:blood; D000818:Animals; D001787:Blood Group Incompatibility / Q000517:prevention & control; D001792:Blood Platelets / Q000166:cytology*; D001793:Blood Preservation / Q000379:methods*; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D017713:Platelet Transfusion / Q000379:methods*; D010983:Plateletpheresis
chemical_list: D000017:ABO Blood-Group System; D007518:Isoantibodies